Skip to main content
logo
BioCryst Pharmaceuticals, Inc. (BCRX)
NASDAQ: BCRX · Real-Time Price · USD
10.34
+0.50 (5.08%)
At close: Aug 11, 2026, 4:00 PM EDT
10.23
-0.11 (-1.06%)
After-hours: Aug 11, 2026, 7:34 PM EDT

BioCryst Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
159.4874.84450.71331.41270.83157.17
Revenue Growth
36.14%94.10%36.00%22.37%72.31%782.38%
Gross Profit
138.47855.76438.44326.93264.42149.94
Operating Income
-1,094340.99-2.54-103.71-148.44-177.72
Net Income
-384.67263.86-88.88-226.54-247.12-184.06
Earnings Per Share
-1.501.21-0.43-1.18-1.33-1.03
EPS Growth
------

Revenue by Geography
Chart
Fiscal YearFY 2025FY 2024FY 2023
Period EndingDec '25 Dec '24 Dec '23
United States
548.78385.96288.36
Outside United States
53.0651.737.63
Unallocated
27313.055.42
Total
874.84450.71331.41

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
352.57274.75320.85388.99424.31507.6
Total Debt
848.97477.33841.42848.71742.68594.66
Net Cash (Debt)
-496.39-202.58-520.57-459.73-318.37-87.06
Net Cash Growth
------
Net Cash Per Share
-2.10-0.93-2.52-2.39-1.71-0.49

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
376.14347.37-52.02-95.14-161.85-142.16
Capital Expenditures
-2.76-2.47-1.12-2.17-1.25-2.39
Free Cash Flow
373.38344.9-53.14-97.31-163.1-144.54
Free Cash Flow Growth
2268.99%-----

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
86.87%97.82%97.28%98.65%97.63%95.40%
Operating Margin
-686.58%38.98%-0.56%-31.29%-54.81%-113.07%
Pretax Margin
-239.15%30.56%-19.29%-68.26%-90.24%-115.68%
Profit Margin
-241.33%30.16%-19.72%-68.36%-91.25%-117.11%
FCF Margin
234.25%39.42%-11.79%-29.36%-60.22%-91.97%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-6.45----
Forward PE
25.1233.02----
P/FCF Ratio
7.084.82----
PS Ratio
2.811.903.483.727.9716.25